Moving Beyond the Pill: Unlocking Value Through Engaged, Empowered, and Educated Patients
July 30, 2026 | Health Outcomes, Impetus Digital, Market Access, Medical Innovation, PSP, Pharma Strategy, Value-based care, beyond the pill, digital health, digital voice, health innovation, health literacy, patient activation, patient engagement, patient support program, patientcentricity, real world data, treatment adherence
True “beyond-the-pill” strategy requires shifting from a prescriptive model to a supportive one—using personalized digital tools and authentic patient voices to drive adherence, improve outcomes, and prove value.
The healthcare ecosystem is undergoing a fundamental, albeit gradual and sometimes painfully slow, transformation, shifting from a volume-based model—where prescription volume is prioritized—to one driven by value-based care. In this beyond-the-pill model, emphasis is placed not only on clinical outcomes, but also on real-world patient experiences. At a time when patients demand greater transparency and control over their health journey, patient engagement is no longer a nice-to-have feature or a regulatory checkmark for Pharma—it is a measurable driver of long-term commercial sustainability.
The efficacy of even the most innovative therapies can be fundamentally eroded by poor adherence, low health literacy, and disconnected care pathways. To overcome these issues, creating an environment where the patient is recognized as an active participant in their care journey, empowered to understand and manage their condition, is critical.
Key Elements to Ensure Activated and Involved Patients
1. Shared Decision-making
First and foremost, improved patient activation requires shared decision-making (SDM). SDM can be defined as a collaborative process that merges clinical evidence with the patient’s values, preferences, and lifestyle to select the optimal treatment path. For Pharma, this represents a crucial strategic shift: moving away from a prescriptive model (Pharma → Prescriber → Patient) to a supportive model that enhances HCP-patient dialogue.
This supportive approach can take many shapes, but one of the most straightforward involves developing tools and resources that enable open, balanced HCP-patient conversations. There is no limit to what this can look like, but popular examples include interactive symptom trackers, risk/benefit calculators, eDiaries, and easy-to-use digital decision aids that direct patients to pertinent information based on their individual demographic and clinical characteristics or risk factors, along with printed and digital educational materials covering the topics that matter most to patients. By investing in SDM support tools, Pharma can help ensure patients not only start therapy but also align psychologically with it, setting the foundation for long-term adherence and treatment success.
2. Personalization
The second key factor is radical personalization. Moving beyond basic patient segmentation, true personalization means addressing the patient’s unique and complex barriers and needs. This includes social determinants of health (SDoH), health literacy gaps, logistical hurdles, and/or underlying emotional states…
Read the full article
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Improving Health Through Integrated & Personalized Patient Care
Hicham Naim, Global Head, Integrated & Personalized Patient Care Program, Digital Advisory Board at Takeda & Founder of Curated Health, explores digital medicine & biomarkers, outcomes-based business models, Software as…
Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to…
Investigating the Complexities of the Canadian & Global Health Systems
The Honourable Tony Clement, Co-chair at Reshoring Canada and former Minister of Health, discusses digital transformation, the importance of onshore manufacturing and supply chain operations in Canada, current pharmaceutical regulatory…
Impetus Digital Overview
Virtual engagement experts helping life science companies have ongoing conversations with their customers through our best-in-class online collaboration tools. Best-In-Class Collaboration Technology Impetus Digital provides two turn-key software solutions through…
Using Technology-Enabled Human Interactions to Transform the Home into a Site of Care
Sara Aghvami, Director of Best Buy Health at Best Buy Canada, explores the concept of “helpful homes” and the role of digital health in enabling “aging in place.” She also…
Realizing the Potential of Genomics-Driven Precision Medicine
Jennifer Helfer, Senior Director, Patient Advocacy & Engagement at Encoded Therapeutics Inc., discusses genomics-driven precision medicine, gene therapy misconceptions and fears, involving patients and caregivers in designing gene therapy trials,…
Helping Patients Become Active Participants in Their Own Care
Rishi Nayyar, Co-founder & CEO of PocketHealth, explores how releasing medical imaging records straight to patients can result in data moving more ethically, easily, and securely. He also shares his…
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions.
Impact of COVID-19 on the Biopsychosocial Model of Health
Dr. Tarry Ahuja, Manager of Program Development in Pharmaceutical Reviews and Senior RWE Advisor at CADTH, explores the impact of COVID-19 on the biopsychosocial model of health, key opportunities and…
Leaders in Pharma: Fran Milnes
In this episode of Impetus Digital’s Leaders in Pharma podcast, I sit down with Fran Milnes. She is currently the Head of Marketing and Commercial Excellence in Oncology at Novartis.